Cargando…

Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) clinical settings cannot do without molecular testing to confirm or rule out predictive biomarkers for prognostic stratification, in order to initiate or withhold targeted therapy. Next generation sequencing offers the advantage of the simultaneous investigation of numer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cumbo, Cosimo, Minervini, Crescenzio Francesco, Orsini, Paola, Anelli, Luisa, Zagaria, Antonella, Minervini, Angela, Coccaro, Nicoletta, Impera, Luciana, Tota, Giuseppina, Parciante, Elisa, Conserva, Maria Rosa, Spinelli, Orietta, Rambaldi, Alessandro, Specchia, Giorgina, Albano, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947272/ https://www.ncbi.nlm.nih.gov/pubmed/31835432 http://dx.doi.org/10.3390/genes10121026

Ejemplares similares

Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2021)

Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia
por: Orsini, Paola, et al.
Publicado: (2018)

TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2016)

Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for “personalized monitoring” of residual disease in chronic myeloid leukemia patients
por: Cumbo, Cosimo, et al.
Publicado: (2018)

Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2020)

IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
por: Conserva, Maria Rosa, et al.
Publicado: (2023)

Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies
por: Orsini, Paola, et al.
Publicado: (2018)

Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia
por: Albano, Francesco, et al.
Publicado: (2015)

Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia
por: Minervini, Angela, et al.
Publicado: (2016)

Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?
por: Zagaria, Antonella, et al.
Publicado: (2017)

The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms
por: Parciante, Elisa, et al.
Publicado: (2023)

Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA
por: Coccaro, Nicoletta, et al.
Publicado: (2023)

ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia
por: Tota, Giuseppina, et al.
Publicado: (2014)

IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis
por: Cumbo, Cosimo, et al.
Publicado: (2021)

Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation
por: Albano, Francesco, et al.
Publicado: (2013)

The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis
por: Zagaria, Antonella, et al.
Publicado: (2022)

Epitranscriptomics in Normal and Malignant Hematopoiesis
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2020)

5′RUNX1-3′USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications
por: Zagaria, Antonella, et al.
Publicado: (2014)

Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?
por: Cumbo, Cosimo, et al.
Publicado: (2022)

Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia
por: Albano, Francesco, et al.
Publicado: (2013)

Case report: biallelic DNMT3A mutations in acute myeloid leukemia
por: Cumbo, Cosimo, et al.
Publicado: (2023)

TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
por: Cumbo, Cosimo, et al.
Publicado: (2020)

HMGA Proteins in Hematological Malignancies
por: Minervini, Angela, et al.
Publicado: (2020)

SETBP1 dysregulation in congenital disorders and myeloid neoplasms
por: Coccaro, Nicoletta, et al.
Publicado: (2017)

Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies
por: Coccaro, Nicoletta, et al.
Publicado: (2020)

SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia
por: Albano, Francesco, et al.
Publicado: (2012)

Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?
por: Cumbo, Cosimo, et al.
Publicado: (2022)

Exploring the Potential of Eltrombopag: Room for More?
por: Tarantini, Francesco, et al.
Publicado: (2022)

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
por: Tarantini, Francesco, et al.
Publicado: (2021)

Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick
por: Tarantini, Francesco, et al.
Publicado: (2021)

Next-Generation Sequencing in Acute Lymphoblastic Leukemia
por: Coccaro, Nicoletta, et al.
Publicado: (2019)

The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia
por: Conserva, Maria Rosa, et al.
Publicado: (2019)

PB2200: CLONAL HEMATOPOIESIS AT THE CROSSROADS OF INFLAMMATORY BOWEL DISEASES AND HEMATOLOGICAL MALIGNANCIES: A BIOLOGICAL LINK?
por: Cumbo, C., et al.
Publicado: (2022)

Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?
por: Coccaro, Nicoletta, et al.
Publicado: (2020)

RARG Gene Dysregulation in Acute Myeloid Leukemia
por: Conserva, Maria Rosa, et al.
Publicado: (2019)

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
por: Cumbo, Cosimo, et al.
Publicado: (2020)

Single-Cell Sequencing: Ariadne’s Thread in the Maze of Acute Myeloid Leukemia
por: Redavid, Immacolata, et al.
Publicado: (2022)

The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?
por: Anelli, Luisa, et al.
Publicado: (2018)

Monosomal karyotype in myeloid neoplasias: a literature review
por: Anelli, Luisa, et al.
Publicado: (2017)

Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers
por: Anelli, Luisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bf7udvlvidd4k6ji2rujuvkii6